Analytical Study of Amalaki Churna as a Rasayana in the Management of Khalitya (Hair Fall)

Background: Hair loss (Khalitya) is a major concern affecting quality of life. In Ayurveda, Amalaki (Emblica officinalis) is described as a premier Rasayana and Keshya drug. Aim: To analytically evaluate the efficacy of Amalaki Churna as a Rasayana in patients with hair fall. Methods: An open-label, single-arm clinical study was conducted on 30 patients with non-cicatricial hair fall for 60 days. Amalaki Churna 3g BID with lukewarm water was administered after food. Assessment was performed using a 60-second hair-comb test, tracheoscopy and subjective parameters on days 0, 30, and 60. Results: Statistically significant reduction in hair fall count (p<0.001), improvement in hair tensile strength, and reduction in Keshalpata and Darunaka symptoms were observed. No adverse effects were reported. Conclusion: Amalaki Churna shows promising Rasayana and Keshya effects in hair fall, likely due to its antioxidant, vitamin C, and Tridoshahara properties.